Olanzapine ODT 10mg Tablets

Manufacturer DR.REDDY'S Active Ingredient Olanzapine Orally Disintegrating Tablets(oh LAN za peen) Pronunciation oh LAN za peen
WARNING: There is a higher chance of death in older adults who take this drug for mental problems caused by dementia. Most of the deaths were linked to heart disease or infection. This drug is not approved to treat mental problems caused by dementia. @ COMMON USES: It is used to treat bipolar disorder. It is used to treat schizophrenia.It is used to treat depression.It may be given to you for other reasons. Talk with the doctor.
đŸˇī¸
Drug Class
Atypical Antipsychotic
đŸ§Ŧ
Pharmacologic Class
Thienobenzodiazepine; Dopamine and Serotonin Receptor Antagonist
🤰
Pregnancy Category
C
✅
FDA Approved
Sep 2000
âš–ī¸
DEA Schedule
Not Controlled

Overview

â„šī¸

What is this medicine?

Olanzapine ODT is a medication used to treat mental health conditions like schizophrenia and bipolar disorder. It belongs to a group of medicines called 'atypical antipsychotics.' It works by helping to balance certain natural chemicals in the brain. The ODT (Orally Disintegrating Tablet) form dissolves quickly in your mouth without water.
📋

How to Use This Medicine

Taking Your Medication Correctly

To get the most benefit from your medication, follow your doctor's instructions carefully. Read all the information provided with your prescription and follow the instructions closely.

Stay hydrated by drinking plenty of non-caffeinated liquids, unless your doctor advises you to limit your fluid intake.
Be cautious in hot weather or when engaging in physical activity, and drink plenty of fluids to prevent dehydration.
You can take this medication with or without food. If it causes stomach upset, take it with food to help minimize this side effect.
Continue taking your medication as directed by your doctor or healthcare provider, even if you start to feel better.

Special Instructions for Taking Your Medication

When opening the foil packaging, do not push the tablet out. Instead, use dry hands to remove it from the foil.
Place the tablet on your tongue and let it dissolve. You do not need to drink water with it. Do not swallow the tablet whole, and avoid chewing, breaking, or crushing it.
If you have phenylketonuria (PKU), consult with your doctor before taking this medication, as some products may contain phenylalanine.

Storing and Disposing of Your Medication

Store your medication at room temperature, protected from light and moisture. Do not store it in a bathroom.
Use the oral-disintegrating tablet immediately after opening the pouch. Discard any unused portion of the pouch.
Keep all medications in a safe and secure location, out of the reach of children and pets.

What to Do If You Miss a Dose

If you miss a dose, take it as soon as you remember.
If it is close to the time for your next dose, skip the missed dose and resume your regular dosing schedule.
* Do not take two doses at the same time or take extra doses to make up for a missed dose.
💡

Lifestyle & Tips

  • Take exactly as prescribed; do not stop abruptly without consulting your doctor.
  • Do not chew or crush the ODT tablet; allow it to dissolve on your tongue and then swallow.
  • Be aware of potential for significant weight gain; monitor your diet and exercise regularly.
  • Monitor blood sugar and cholesterol levels regularly as advised by your doctor.
  • Avoid alcohol and other CNS depressants, as they can increase sedation.
  • Be cautious when driving or operating machinery until you know how the medication affects you, due to potential for drowsiness or dizziness.
  • Stay hydrated, especially in hot weather, as olanzapine can affect body temperature regulation.

Dosing & Administration

đŸ‘¨â€âš•ī¸

Adult Dosing

Standard Dose: Schizophrenia: Initial 5-10 mg once daily. Target 10 mg/day. Bipolar I Disorder (Manic or Mixed Episodes): Initial 10-15 mg once daily (monotherapy) or 10 mg once daily (combination). Target 5-20 mg/day. Bipolar I Disorder (Maintenance): 5-20 mg once daily.
Dose Range: 5 - 20 mg

Condition-Specific Dosing:

schizophrenia: Initial 5-10 mg/day, target 10 mg/day. Max 20 mg/day.
bipolar_manic_mixed: Initial 10-15 mg/day (monotherapy) or 10 mg/day (combination). Max 20 mg/day.
bipolar_maintenance: 5-20 mg/day.
đŸ‘ļ

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: Not established
Adolescent: Approved for Schizophrenia and Bipolar I Disorder (manic or mixed episodes) in adolescents (13-17 years). Initial 2.5-5 mg once daily. Target 10 mg/day. Max 20 mg/day. Lower initial doses (2.5 mg) and slower titration may be considered due to higher incidence of weight gain and sedation.
âš•ī¸

Dose Adjustments

Renal Impairment:

Mild: No dosage adjustment generally required.
Moderate: No dosage adjustment generally required.
Severe: No dosage adjustment generally required, but caution is advised.
Dialysis: Not significantly removed by dialysis. No specific adjustment, but caution and monitoring are advised.

Hepatic Impairment:

Mild: No dosage adjustment generally required.
Moderate: Consider lower initial dose (e.g., 5 mg/day) and slower titration. Caution advised.
Severe: Not recommended due to lack of data and potential for increased exposure. Use with extreme caution if at all.

Pharmacology

đŸ”Ŧ

Mechanism of Action

Olanzapine is an atypical antipsychotic with affinity for a number of neurotransmitter receptors. Its antipsychotic activity is thought to be mediated through a combination of antagonism at dopamine D2 and serotonin 5-HT2A receptors. It also has affinity for 5-HT2C, 5-HT3, 5-HT6, D1, D3, D4, muscarinic M1-M5, alpha-1 adrenergic, and histamine H1 receptors.
📊

Pharmacokinetics

Absorption:

Bioavailability: 60-80%
Tmax: 5-8 hours (for conventional tablet, ODT is similar)
FoodEffect: Food does not affect the rate or extent of absorption.

Distribution:

Vd: 1000-1800 L
ProteinBinding: Approximately 93% (primarily to albumin and alpha1-acid glycoprotein)
CnssPenetration: Yes

Elimination:

HalfLife: 21-54 hours (mean 33 hours)
Clearance: Approximately 25 L/hr (variable)
ExcretionRoute: Urine (57%), Feces (30%)
Unchanged: Approximately 7% (urine)
âąī¸

Pharmacodynamics

OnsetOfAction: Within days to weeks for full therapeutic effect, but sedation may occur within hours.
PeakEffect: Several weeks for optimal antipsychotic effect.
DurationOfAction: Once daily dosing due to long half-life.

Safety & Warnings

âš ī¸

BLACK BOX WARNING

Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. Olanzapine is not approved for the treatment of patients with dementia-related psychosis.
âš ī¸

Side Effects

Urgent Side Effects: Seek Medical Help Right Away

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek medical attention immediately:

Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of high blood sugar, including:
+ Confusion
+ Feeling sleepy
+ Unusual thirst or hunger
+ Passing urine more often
+ Flushing
+ Fast breathing
+ Breath that smells like fruit
Neurological symptoms, such as:
+ Trouble controlling body movements
+ Twitching
+ Change in balance
+ Trouble swallowing or speaking
Mental, mood, or behavior changes that are new or worsening, including thoughts of hurting yourself or suicide
Severe dizziness or passing out
Abnormal heartbeat (fast or slow)
Not sweating during activities or in warm temperatures
Seizures
Drooling
Changes in eyesight
Memory problems or loss
Chest pain
Swelling
Burning, numbness, or tingling sensations that are not normal
Trouble passing urine
Hormonal changes, including:
+ Enlarged breasts
+ Nipple discharge
+ Erectile dysfunction
+ Menstrual changes
Swollen glands
Neuroleptic malignant syndrome (NMS), a rare but potentially life-threatening condition, characterized by:
+ Fever
+ Muscle cramps or stiffness
+ Dizziness
+ Severe headache
+ Confusion
+ Changes in thinking
+ Fast heartbeat
+ Abnormal heartbeat
+ Excessive sweating
Low white blood cell count, which can increase the risk of infection; if you have a history of low white blood cell count, inform your doctor and seek medical attention if you experience:
+ Fever
+ Chills
+ Sore throat
Tardive dyskinesia, a severe muscle problem, characterized by:
+ Trouble controlling body movements
+ Problems with your tongue, face, mouth, or jaw, such as tongue sticking out, puffing cheeks, mouth puckering, or chewing

Other Possible Side Effects

While many people may not experience any side effects or only minor ones, it is essential to be aware of the following potential side effects:

Feeling dizzy, sleepy, tired, or weak
Restlessness
Shakiness
Headache
Constipation
Dry mouth
Upset stomach
Weight gain
Increased appetite
Back pain
Joint pain
Trouble sleeping

If any of these side effects bother you or do not go away, contact your doctor or seek medical attention. This is not an exhaustive list of possible side effects. If you have questions or concerns, consult your doctor.

Reporting Side Effects

You can report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch. Your doctor can also provide guidance on managing side effects and offer medical advice.
🚨

Seek Immediate Medical Attention If You Experience:

  • Excessive drowsiness or dizziness, especially when standing up (orthostatic hypotension)
  • Uncontrolled muscle movements (e.g., face, tongue, limbs) - signs of tardive dyskinesia
  • High fever, stiff muscles, confusion, sweating, fast or irregular heartbeat (signs of Neuroleptic Malignant Syndrome - NMS)
  • Increased thirst, increased urination, increased hunger, blurred vision (signs of high blood sugar)
  • Unexplained weight gain
  • Difficulty swallowing or breathing
  • Rash or allergic reaction
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the symptoms you experienced as a result of the allergy.
All medications you are currently taking, including prescription and over-the-counter (OTC) drugs, natural products, and vitamins. This information will help your doctor and pharmacist assess potential interactions between this medication and other substances you are taking.
* Any existing health problems, as this medication may interact with certain conditions.

To ensure your safety, it is crucial to verify that it is safe to take this medication with all your current medications and health conditions. Never start, stop, or adjust the dose of any medication without first consulting your doctor.
âš ī¸

Precautions & Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication.

When starting this medication, be cautious when driving or engaging in activities that require your full attention, as it may affect your alertness. To minimize the risk of dizziness or fainting, get up slowly from a sitting or lying position, and be careful when climbing stairs.

This medication may increase your risk of developing high blood sugar, diabetes, high cholesterol, and weight gain, which can contribute to heart and brain blood vessel disease. Monitor your blood sugar levels as instructed by your doctor, and undergo regular blood tests and other laboratory evaluations as recommended.

Avoid consuming alcohol while taking this medication. Before using marijuana, cannabis, or any prescription or over-the-counter drugs that may cause drowsiness, consult with your doctor.

This medication can cause dizziness, drowsiness, and impaired balance, which may increase your risk of falls and related injuries, such as fractures.

In rare cases, this medication can cause a severe and potentially life-threatening reaction, characterized by symptoms such as fever, rash, swollen glands, and organ dysfunction (e.g., liver, kidney, blood, heart, muscles, joints, or lungs). If you have any concerns, discuss them with your doctor.

Elderly patients with dementia who take this type of medication have a higher risk of experiencing strokes, which can be fatal. This medication is not approved for treating dementia-related mental health issues. If you are 65 or older, use this medication with caution, as you may be more susceptible to side effects.

When administering this medication to children, exercise caution, as they may be at a higher risk of experiencing certain side effects.

This medication may affect fertility, but this effect is typically reversible when the medication is discontinued. If you have questions or concerns, consult with your doctor.

If you are pregnant, planning to become pregnant, or breastfeeding, inform your doctor, as they will need to discuss the potential benefits and risks to you and your baby. Taking this medication during the third trimester of pregnancy may cause side effects or withdrawal symptoms in the newborn.
🆘

Overdose Information

Overdose Symptoms:

  • Drowsiness
  • Slurred speech
  • Agitation
  • Tachycardia (fast heart rate)
  • Extrapyramidal symptoms (e.g., tremors, muscle stiffness)
  • Coma
  • Respiratory depression
  • Hypotension

What to Do:

Seek immediate medical attention. Call 911 or Poison Control at 1-800-222-1222. Treatment is supportive, including maintaining airway, oxygenation, and ventilation, and managing symptoms.

Drug Interactions

🔴

Major Interactions

  • CNS depressants (e.g., alcohol, benzodiazepines, opioids): Increased risk of sedation, respiratory depression, hypotension.
  • Anticholinergic drugs (e.g., benztropine, tricyclic antidepressants): Potentiation of anticholinergic effects (e.g., severe constipation, urinary retention, heat intolerance).
  • Dopamine agonists (e.g., levodopa, bromocriptine): Olanzapine may antagonize their effects.
  • Drugs that prolong QT interval (e.g., quinidine, sotalol, certain antipsychotics): Additive risk of QT prolongation, though olanzapine's effect is minimal.
🟡

Moderate Interactions

  • CYP1A2 inhibitors (e.g., fluvoxamine, ciprofloxacin): May increase olanzapine plasma concentrations, requiring dose reduction.
  • CYP1A2 inducers (e.g., carbamazepine, rifampin, omeprazole, smoking): May decrease olanzapine plasma concentrations, requiring dose increase.
  • Antihypertensive agents: Additive hypotensive effects, especially orthostatic hypotension.
  • Valproate: Increased incidence of weight gain, neutropenia, and tremor when co-administered with olanzapine.
đŸŸĸ

Minor Interactions

  • Lithium: No significant pharmacokinetic interaction, but monitor for additive CNS effects.
  • Cimetidine, antacids: No significant effect on olanzapine absorption.

Monitoring

đŸ”Ŧ

Baseline Monitoring

Weight/BMI

Rationale: Risk of significant weight gain.

Timing: Before initiation

Fasting Plasma Glucose/HbA1c

Rationale: Risk of hyperglycemia and new-onset diabetes.

Timing: Before initiation

Lipid Panel (Fasting)

Rationale: Risk of dyslipidemia.

Timing: Before initiation

Blood Pressure

Rationale: Risk of orthostatic hypotension.

Timing: Before initiation

Personal/Family History of Cardiovascular Disease, Diabetes, Dyslipidemia

Rationale: Identify risk factors for metabolic adverse effects.

Timing: Before initiation

ECG

Rationale: Consider for patients with known cardiovascular disease or risk factors, though olanzapine's QT effect is minimal.

Timing: Before initiation (if indicated)

📊

Routine Monitoring

Weight/BMI

Frequency: Monthly for first few months, then quarterly.

Target: Maintain healthy range; monitor for significant increase (>7% baseline).

Action Threshold: Significant weight gain; consider lifestyle interventions, dose adjustment, or alternative.

Fasting Plasma Glucose/HbA1c

Frequency: At 3 months, then annually (or more frequently if risk factors present).

Target: FPG <100 mg/dL; HbA1c <5.7%.

Action Threshold: Elevated glucose/HbA1c; consider lifestyle, metformin, or alternative.

Lipid Panel (Fasting)

Frequency: At 3 months, then annually (or more frequently if risk factors present).

Target: LDL <100 mg/dL, HDL >40 mg/dL (men), >50 mg/dL (women), Triglycerides <150 mg/dL.

Action Threshold: Dyslipidemia; consider lifestyle, statins, or alternative.

Blood Pressure

Frequency: At each visit, especially during titration.

Target: <120/80 mmHg.

Action Threshold: Orthostatic hypotension or sustained hypertension; consider dose adjustment or intervention.

Extrapyramidal Symptoms (EPS) / Tardive Dyskinesia (TD) (e.g., AIMS scale)

Frequency: At each visit, or at least every 6-12 months.

Target: Absence of abnormal involuntary movements.

Action Threshold: Emergence or worsening of EPS/TD; consider dose reduction, switching agent, or adjunctive treatment.

Sedation/Alertness

Frequency: At each visit, especially during initiation.

Target: Functional level of alertness.

Action Threshold: Excessive sedation impacting daily function; consider dose adjustment or timing.

đŸ‘ī¸

Symptom Monitoring

  • Excessive sedation or somnolence
  • Dizziness or lightheadedness (orthostatic hypotension)
  • Unusual weight gain or increased appetite
  • Increased thirst or urination (signs of hyperglycemia)
  • Muscle stiffness, tremors, restlessness (EPS)
  • Involuntary movements of face, tongue, or limbs (TD)
  • Constipation or urinary retention (anticholinergic effects)
  • Changes in mood or behavior (worsening of symptoms or emergence of new ones)
  • Signs of neuroleptic malignant syndrome (fever, muscle rigidity, altered mental status, autonomic instability)

Special Patient Groups

🤰

Pregnancy

Category C. Use during pregnancy only if the potential benefit justifies the potential risk to the fetus. Neonates exposed to antipsychotic drugs during the third trimester are at risk for extrapyramidal and/or withdrawal symptoms following delivery.

Trimester-Specific Risks:

First Trimester: Limited data, but no clear evidence of increased major malformation risk.
Second Trimester: No specific increased risks identified.
Third Trimester: Risk of extrapyramidal and/or withdrawal symptoms in neonates (e.g., agitation, tremor, hypertonia, hypotonia, respiratory distress, feeding disorder). Monitor neonates for these symptoms.
🤱

Lactation

L3 (Moderately safe). Olanzapine is excreted into breast milk. Monitor breastfed infants for sedation, irritability, poor feeding, and developmental milestones. Consider risks vs. benefits; alternative agents with lower milk transfer or formula feeding may be considered.

Infant Risk: Moderate risk. Potential for sedation, poor feeding, and weight gain in the infant. Long-term effects unknown.
đŸ‘ļ

Pediatric Use

Approved for schizophrenia and bipolar I disorder (manic or mixed episodes) in adolescents (13-17 years). Higher incidence of weight gain, increased lipids, and sedation compared to adults. Careful monitoring of metabolic parameters is crucial.

👴

Geriatric Use

Increased risk of death in elderly patients with dementia-related psychosis (Black Box Warning). Increased susceptibility to orthostatic hypotension, sedation, and anticholinergic effects. Use lower initial doses and titrate slowly. Monitor for falls and cognitive impairment.

Clinical Information

💎

Clinical Pearls

  • Olanzapine ODT should be administered immediately upon removal from the blister pack. Do not store it outside the blister pack.
  • The ODT formulation is beneficial for patients who have difficulty swallowing pills or who may be non-adherent with conventional tablets.
  • Significant metabolic side effects (weight gain, dyslipidemia, hyperglycemia) are common with olanzapine. Proactive monitoring and lifestyle interventions are essential.
  • Orthostatic hypotension is a common side effect, especially during initial titration. Advise patients to rise slowly from a sitting or lying position.
  • Smoking can significantly reduce olanzapine levels due to CYP1A2 induction, potentially requiring higher doses in smokers.
  • Consider the risk of tardive dyskinesia with long-term use; periodically assess for abnormal involuntary movements using a standardized scale (e.g., AIMS).
🔄

Alternative Therapies

  • Other atypical antipsychotics (e.g., risperidone, quetiapine, aripiprazole, ziprasidone, lurasidone, cariprazine, brexpiprazole)
  • First-generation antipsychotics (e.g., haloperidol, chlorpromazine) - generally less preferred due to higher EPS risk
  • Mood stabilizers (e.g., lithium, valproate, lamotrigine) for bipolar disorder
  • Antidepressants (for bipolar depression, often in combination with a mood stabilizer or antipsychotic)
💰

Cost & Coverage

Average Cost: Varies widely, typically $30-$150 per 30 tablets (10mg generic ODT)
Generic Available: Yes
Insurance Coverage: Tier 1 or Tier 2 (generic)
📚

General Drug Facts

If your symptoms or health issues persist or worsen, it's essential to contact your doctor for further guidance. To ensure your safety, never share your medication with others or take someone else's medication.

This medication is accompanied by a Medication Guide, which provides crucial information about its use. Please read this guide carefully and review it again whenever you receive a refill. If you have any questions or concerns about this medication, don't hesitate to discuss them with your doctor, pharmacist, or other healthcare provider.

In the event of a suspected overdose, immediately call your local poison control center or seek emergency medical attention. When reporting the incident, be prepared to provide details about the medication taken, the amount, and the time it occurred.